Poulton Stuart
Insider CIK 1942597 · KPTI EVP, Chief Development Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KPTI Karyopharm Therapeutics In | S Sale | 2026-07-28 | 2026-07-30 | 189 | $7.10 | $1.3K | 94,632 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2026-07-28 | 2026-07-30 | 189 | $7.10 | $1.3K | 94,632 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2026-05-14 | 2026-05-15 | 403 | $9.50 | $3.8K | 94,821 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2026-05-13 | 2026-05-15 | 896 | — | $0 | 95,224 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2026-03-02 | 2026-03-03 | 5,101 | $9.41 | $48.0K | 94,328 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2026-02-17 | 2026-02-19 | 378 | $8.63 | $3.3K | 99,429 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2026-01-31 | 2026-02-03 | 32,415 | — | $0 | 99,807 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2025-10-15 | 2025-10-16 | 39,682 | — | $0 | 67,392 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2025-09-15 | 2025-09-16 | 401 | $6.43 | $2.6K | 27,710 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2025-09-12 | 2025-09-16 | 888 | — | $0 | 28,111 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2025-07-29 | 2025-07-30 | 191 | $4.37 | $835 | 27,223 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2025-03-04 | 2025-03-06 | 3,548 | $6.29 | $22.3K | 27,414 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2025-02-28 | 2025-03-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2025-02-28 | 2025-03-04 | 9,166 | — | $0 | 9,166 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2025-02-28 | 2025-03-04 | 4,583 | — | $0 | 30,962 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2025-02-28 | 2025-03-04 | 5,000 | — | $0 | 26,379 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2025-02-18 | 2025-02-19 | 5,914 | $0.63 | $3.7K | 320,714 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-07-30 | 2024-07-31 | 2,883 | $1.06 | $3.1K | 326,628 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-03-01 | 2024-03-04 | 6,155 | $1.20 | $7.4K | 329,511 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-02-29 | 2024-03-04 | 16,311 | $1.17 | $19.1K | 335,666 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2024-02-28 | 2024-02-29 | 188,205 | — | $0 | 351,977 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-02-15 | 2024-02-20 | 99 | $1.40 | $139 | 163,772 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-02-15 | 2024-02-20 | 5,748 | $1.33 | $7.6K | 163,871 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2024-01-24 | 2024-01-25 | 13,333 | — | $0 | 169,619 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-07-28 | 2023-08-01 | 2,845 | $1.70 | $4.8K | 156,286 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2023-02-28 | 2023-03-02 | 95,000 | — | $0 | 159,131 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-02-15 | 2023-02-17 | 5,665 | $3.19 | $18.1K | 64,335 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-02-15 | 2023-02-17 | 196 | $3.16 | $619 | 64,131 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-02-15 | 2023-02-17 | 8 | $3.23 | $26 | 64,327 | SEC↗ |